![](/img/cover-not-exists.png)
EFFICACY AND SAFETY OF TEVERELIX, A NEW GONADOTROPHIN RELEASING HORMONE ANTAGONIST IN PATIENTS WITH ADVANCED PROSTATE CANCER. RESULTS FROM A PHASE 2 MULTICENTRE, OPEN-LABEL, PILOT STUDY INVESTIGATING AN INITIAL INTRAMUSCULAR LOADING DOSE REGIMEN OF TEVERELIX
C. Maclean, A. Ulys, F. Jankevičius, D. Kaniušas, J. Drewe, F. LarsenVolume:
5
Year:
2006
Language:
english
DOI:
10.1016/s1569-9056(06)60921-4
File:
PDF, 70 KB
english, 2006